Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study reveals increasing drug resistance of parasitic nematodes
Horse
Cyathostomins can be life-threatening in horses when they are present in large numbers.
Results highlight the threat of increasing drug resistance in worm populations

New research carried out by scientists at the Moredun Research Institute in Edinburgh, in collaboration with the Universities of Liverpool and Bristol, has highlighted the threat of multi-drug resistance in worm populations infecting horses.
 
The study investigated the efficacy of antihelmintic drugs in treating cyathostomins, a group of parasitic nematodes (worms) that are highly prevalent in horses, and may be life threatening in large numbers.
 
Antihelmintic drugs have been used indiscriminately to control these worms in horses for the last 40 years, but the results show that the drugs are not controlling the parasite as effectively as they used to.
 
Published this week in the International Journal for Parasitology, the study analyses the efficacy of the four available broad spectrum antihelmintic drugs, on 16 thoroughbred stud farms in the UK. The percentage reduction of cyathostomin worm egg counts found in the faeces of the horses after treatment was calculated, as well as the time to egg re-appearance following treatment.
 
The results revealed that while Ivermectin and Moxidectin showed acceptable efficacy at two weeks post-treatment, the time period to the reappearance of worm eggs in the faeces of the horses was shorter than previously observed.
 
Worm resistance was measured at two weeks post treatment, and observed against the other two antihelmintic products examined, Fenbendazole and Pyrantel. Resistance to Ivermectin was also identified in the common roundworm of foals, Parascaris equorum.
 
Professor Jaqueline Matthews, deputy director at Moredun, said: “These results from a comprehensive study involving several thoroughbred stud farms suggest that the common antihelmintic products are working less effectively than measured previously, and indicate the presence of multi-drug resistance.
 
"It is therefore important that more sustainable strategies for worm control be deployed in practice. These involve evidence based protocols using worm egg count analysis to direct treatments at certain times of year (spring and summer) and should be designed with input from a veterinary surgeon or SQP.”
 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.